Time course and frequency of subtherapeutic anticoagulation for newly prescribed warfarin anticoagulation before elective cardioversion of atrial fibrillation or flutter.
Kim
M H
MH
Cardiovascular Division, Washington University, St. Louis, Missouri, USA.
Krishnan
K
K
Jain
S
S
Decena
B F
BF
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000097:blood* / Q000628:therapy*; D001282:Atrial Flutter / Q000097:blood* / Q000628:therapy*; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin